Aspen Pharmacare Holdings Limited

DB:LDZU Stock Report

Market Cap: €3.9b

Aspen Pharmacare Holdings Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Stephen Saad

Chief executive officer

R27.3m

Total compensation

CEO salary percentage35.2%
CEO tenure25yrs
CEO ownership11.8%
Management average tenure7.8yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Stephen Saad's remuneration changed compared to Aspen Pharmacare Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024R27mR10m

R4b

Mar 31 2024n/an/a

R5b

Dec 31 2023n/an/a

R5b

Sep 30 2023n/an/a

R5b

Jun 30 2023R24mR9m

R5b

Mar 31 2023n/an/a

R6b

Dec 31 2022n/an/a

R6b

Sep 30 2022n/an/a

R6b

Jun 30 2022R23mR9m

R6b

Mar 31 2022n/an/a

R6b

Dec 31 2021n/an/a

R6b

Sep 30 2021n/an/a

R5b

Jun 30 2021R24mR8m

R5b

Mar 31 2021n/an/a

R4b

Dec 31 2020n/an/a

R4b

Sep 30 2020n/an/a

R4b

Jun 30 2020R23mR8m

R3b

Mar 31 2020n/an/a

R3b

Dec 31 2019n/an/a

R870m

Sep 30 2019n/an/a

R1b

Jun 30 2019R14mR8m

R2b

Mar 31 2019n/an/a

R3b

Dec 31 2018n/an/a

R5b

Sep 30 2018n/an/a

R5b

Jun 30 2018R17mR7m

R6b

Compensation vs Market: Stephen's total compensation ($USD1.46M) is about average for companies of similar size in the German market ($USD1.89M).

Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Saad (60 yo)

25yrs

Tenure

R27,303,000

Compensation

Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...

Leadership Team

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director25yrsR27.30m11.82%
€ 457.2m
Sean Capazorio
Group CFO & Executive Director26yrsR16.66mno data
Lorraine Hill
Group Chief Operations Officer11.2yrsR17.18mno data
Michael Attridge
Group Chief Advisor3yrsR11.14m4.32%
€ 167.3m
Reginald Haman
Group Chief Corporate Officer & Executive Director1.1yrsR13.79mno data
Zizipho Mmango
Group Chief Strategic Development Officer4.7yrsR12.81mno data
Sibongakonke Nkosi
Investor Relations Managerno datano datano data
Raeesa Khan
Group Company Secretary & Chief of Staffless than a yearno datano data
Trevor Ziman
Regional Chief Executive Officer of Asia Pacific11yrsno datano data
Samer Kassem
Chief Executive Officer of Aspen Global Incorporated7.8yrsno datano data
Luresha Chetty
Corporate Affairs & Investor Relations Executiveno datano datano data

7.8yrs

Average Tenure

54.5yo

Average Age

Experienced Management: LDZU's management team is seasoned and experienced (7.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Saad
Group CEO & Executive Director26yrsR27.30m11.82%
€ 457.2m
Sean Capazorio
Group CFO & Executive Director3yrsR16.66mno data
Reginald Haman
Group Chief Corporate Officer & Executive Directorless than a yearR13.79mno data
Ben Kruger
Lead Independent Non-Executive Director5.8yrsR1.27mno data
Christopher Mortimer
Non-Executive Director26yrsR551.00kno data
Kuseni Dlamini
Independent Non-Executive Chairman12.8yrsR1.49mno data
Yvonne Muthien
Independent Non-Executive Director3.1yrsR1.08mno data
David Redfern
Non-Executive Director9.9yrsR427.00kno data
Linda de Beer
Independent Non-Executive Director6.5yrsR1.14mno data
Neo Dongwana
Independent Non-Executive Directorless than a yearR183.00kno data
Themba Mkhwanazi
Independent Non-Executive Director5.8yrsR432.00kno data

5.8yrs

Average Tenure

57yo

Average Age

Experienced Board: LDZU's board of directors are considered experienced (5.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 15:45
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aspen Pharmacare Holdings Limited is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre BekkerArqaam Capital Research Offshore S.A.L.
Boitshepo SeruweAvior Capital Markets
Simon MatherBarclays